12:00 AM
Oct 15, 2012
 |  BC Week In Review  |  Company News  |  Deals

Leukocare, Trillium Diagnostics deal

Leukocare granted Trillium an exclusive, worldwide license to a patent that covers the quantification of circulating cell-free DNA in plasma or serum samples. Trillium will use the technology to develop...

Read the full 127 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >